INSYS Therapeutics, Inc. operates as a pharmaceutical company, which develops and commercializes supportive care products. It focuses on utilizing commercial pharmaceutical products that include Subsys, a proprietary sublingual fentanyl spray for BTCP in opioid-tolerant adult patients; and Syndros, a proprietary orally administered liquid formulation of dronabinol for the treatment of CINV and anorexia associated with weight loss in patients with AIDS. The company was founded by John N. Kapoor on June 15, 1990 and is headquartered in Chandler, AZ.

Unimed Pharmaceuticals, Inc. manufactured pharmaceutical products. It provided multiple indications in the therapeutic areas of cardiology, men's health, HIV and other infectious diseases. The company was founded in 1999 and was headquartered in Marietta, GA.

Murty Pharmaceuticals, Inc.("MPI") is a pharmaceutical research and development firm that specializes in novel formulations of new and existing chemical entities conducted in strict conformance with applicable cGMPs. For solid oral dosage forms, MPI can develop robust manufacturing processes for exhibit and commercial batches, and can manufacture clinical supplies to meet any client requirements. In addition, MPI provides regulatory support for submissions of NDAs, ANDAs, INDs, and CMCs from the onset, thereby reducing the need for redundant studies and reducing total costs of development.F

Starton Therapeutics, Inc. is an American company located in Paramus, NJ. The firm operates as a clinical-stage biotechnology company focused on transforming therapies with delivery technology. It was founded in 2017 by Pedro Lichtinger, he has been the CEO since the company founding.\nThe company says this about itself: Starton is a clinical-stage biotechnology company focused on transforming standard-of-care therapies with proprietary continuous delivery technology, so people with cancer can receive continuous treatment to live better, longer. To learn more, visit startontx.com.

Spectrum Therapeutics GmbH, a subsidiary of Dermapharm Holding SE, is a company headquartered in Neumarkt, Germany, that manufactures and sells cannabinoids & herbal medicinal products. The firm was founded in 2002. Trine Katborg Davidsen and Paul Leopold Steckler are the current co-CEOs of the company.

Insys Development Co., Inc., a subsidiary of INSYS Therapeutics, Inc., is an American company. The firm manufactures pharmaceutical products.

Part of Purdue Pharma LP, Rhodes Technologies, Inc. is a company headquartered in Coventry, RI. The firm engages in the manufacturing of pharmaceutical products.

Incannex Healthcare Ltd. is a clinical stage pharmaceutical development company, which engages in the research and development associated with medicinal cannabinoid and psychedelic pharmaceutical products and therapies. It operates through the following segments: Psychedelic Products, Cannabinoid Products, and Corporate. The Psychedelic Products segment is involved in the use of psychedelic medicine and therapies for the treatment of mental health disorders. The Cannabinoid Products segment focuses on the use of medicinal cannabinoid products. The Corporate segment consists of management of the organization, capital management, and management of resources. The company was founded on April 27, 2001 and is headquartered in Melbourne, Australia.

THC Pharm GmbH, a subsidiary of Dermapharm Holding SE, is a German company located in Frankfurt that develops drug therapies. It was founded in 1996. Trine Katborg Davidsen and Paul Leopold Steckler are the current co-CEOs of the firm.

Embio Ltd. is a private company headquartered in Mumbai, India, that manufactures pharmaceutical ingredients.

Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ.

Rhodes Pharmaceuticals, a privately held company headquartered in picturesque Rhode Island, has been developing and distributing quality pharmaceutical products since 2008. their product portfolio is continually growing due to first-class R&D, industry partnerships, and strong relationships with their suppliers and independently associated companies. These connections allow us to offer their customers quality products with reliable supply at competitive prices. their products are distributed and available nationwide.

Glaxo Wellcome SA, a subsidiary of GSK Plc, is a company headquartered in Aranda de Duero, Spain. The firm manufactures and markets medicines.

Alphora is an FDA-approved contract research and manufacturing organization focused on process chemistry, cGMP scale up, and analytical method development for complex, small molecule APIs. Our services have supported numerous IND-enabling, clinical, and commercial API technology development programs over the past 13 years.

Daisy Pharma Opioid Venture LLC engages in the provision of pharmaceuticals services. The company was founded on September 20, 2017 and is headquartered in Scottsdale, AZ.

Eon Labs, Inc. manufactures pharmaceuticals and generic drugs. They produce drugs in oral dosage variety and in both immediate and extended release delivery systems. Their products are used in treating arthritis, ulcers, epilepsy, infections and obsessive-compulsive disorder. The company was founded in 1992 and is headquartered in Lake Success, NY.

ENBIO is the inventor , and trustee, of a remarkable technology called CoBlast., which offers industry the potential to redefine the performance, function and value of metals across all sectors. They are a young and vibrant company, operating as a trusted partner in some of industries most regulated and demanding markets, developing and delivering next-generation solutions to meet ever increasing material challenges. ENBIO offers clients the ability to quickly evaluate the potency of the CoBlast technology via its rapid sample production process, or through structured collaborative evaluation studies. Generally, the client identifies the chemistry of a required skin, whilst ENBIO focuses on and enables the practical delivery of such CoBlast chemistries.

Senzer Ltd. is a private company headquartered in Salisbury, UK, that manufactures respiratory devices. It was founded in 2015.\nThe company says this about itself: SENZER Ltd. is a U.K.-based inhalation technology company specializing in the development and commercialization of therapeutic delivery systems of cannabinoid products, and it is developing a pipeline of inhalation and delivery products to meet unmet medical needs. Senzer's platform is based around a patented device that allows swift and effective inhaled delivery of cannabinoids, in a consistent dose-controlled presentation.